Cargando…
Surgery for thoracic oligoprogression in metastatic renal cell cancer in the era of new systemic therapies
BACKGROUND: Novel systemic therapies have improved response rates and survival in metastatic renal cell cancer (mRCC) and are considered standard of care for this entity. However, complete remission (CR) is rare and often oligoprogression is observed. Here, we analyse the role of surgery for oligopr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089849/ https://www.ncbi.nlm.nih.gov/pubmed/37065601 http://dx.doi.org/10.21037/jtd-22-1120 |